Applicant, as named in the Orange Book
Jazz Pharms
Next listed expiry: Xyrem on 15 Sep 2033. 1 products with live protection, 0 without.
Products with listed protection
| Drug | Ingredient | NDA | Earliest generic entry | Basis |
|---|
| Xyrem sodium oxybate | sodium oxybate | 021196 | 15 Sep 2033 | patent |
Recent events
- 25 Oct 2026Luvox Cr · Generic approved 30 Apr 2026
- 25 Oct 2026Luvox Cr · Generic approved 23 Jun 2026
- 25 Oct 2026Xyrem · Generic approved 5 Nov 2025
- 25 Oct 2026Luvox Cr · Generic approved 21 Jul 2026